Washington Post Examines Debate Over Changes In Management Of U.S. Strategic National Stockpile Under Trump Administration

Washington Post: Inside the secret U.S. stockpile meant to save us all in a bioterror attack
“…For nearly two decades, the [Strategic National Stockpile, a government repository of drugs and supplies ready for deployment in public health emergency,] has been almost exclusively managed by the Centers for Disease Control and Prevention. That will change under a Trump administration plan to shift oversight of the $575 million program to a different part of the Department of Health and Human Services. Doing so, proponents say, will keep the program intact but streamline decision-making and create ‘efficiencies.’ But some public health officials and members of Congress in both parties worry the move will disrupt a complex process that relies on long-standing relationships between the federal program and the state and local agencies responsible for distributing the medicine…” (Sun, 4/24).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.